Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T67207 | ||||
Target Name | Low affinity immunoglobulin epsilon Fc receptor | ||||
Synonyms | BLAST2; CD23; Ctype lectin domain family 4 member J; FcepsilonRII; Immunoglobulin Ebinding factor; Low affinity immunoglobulin epsilon Fc receptor; Low affinity immunoglobulin epsilon Fc receptor soluble form; Lymphocyte IgE receptor; FCER2 | ||||
Target Type | Clinical Trial | ||||
Gene Name | FCER2 | ||||
Biochemical Class | Immunoglobulin | ||||
UniProt ID | FCER2_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Acute myelocytic leukemia | ||||
Example drug | Lumiliximab | Phase 2 | [521906], [1572592] | ||
Tissue | Bone marrow | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: -0.10 Z-score: -0.23 P-value: 9.88E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target Gene Expression Profiles in Other Tissues of Healthy Individuals | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.